177 related articles for article (PubMed ID: 23067406)
1. [Subtypes of medulloblastomas: distinct cellular origins].
Bourdeaut F; Pouponnot C; Ayrault O
Med Sci (Paris); 2012 Oct; 28(10):805-9. PubMed ID: 23067406
[No Abstract] [Full Text] [Related]
2. Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas.
Kunder R; Jalali R; Sridhar E; Moiyadi A; Goel N; Goel A; Gupta T; Krishnatry R; Kannan S; Kurkure P; Deopujari C; Shetty P; Biyani N; Korshunov A; Pfister SM; Northcott PA; Shirsat NV
Neuro Oncol; 2013 Dec; 15(12):1644-51. PubMed ID: 24203893
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma: a potpourri of distinct entities.
Pfister S
Acta Neuropathol; 2012 Apr; 123(4):463-4. PubMed ID: 22392443
[No Abstract] [Full Text] [Related]
5. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.
Sutter R; Shakhova O; Bhagat H; Behesti H; Sutter C; Penkar S; Santuccione A; Bernays R; Heppner FL; Schüller U; Grotzer M; Moch H; Schraml P; Marino S
Oncogene; 2010 Mar; 29(12):1845-56. PubMed ID: 20062081
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations target distinct subgroups of medulloblastoma.
Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
[TBL] [Abstract][Full Text] [Related]
7. Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma.
Wang X; Ramaswamy V; Remke M; Mack SC; Dubuc AM; Northcott PA; Taylor MD
Neurosurgery; 2013 Aug; 60 Suppl 1():57-63. PubMed ID: 23839353
[No Abstract] [Full Text] [Related]
8. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
Gupta T; Shirsat N; Jalali R
Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
[TBL] [Abstract][Full Text] [Related]
9. Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.
Iorgulescu JB; Van Ziffle J; Stevers M; Grenert JP; Bastian BC; Chavez L; Stichel D; Buchhalter I; Samuel D; Nicolaides T; Banerjee A; Mueller S; Gupta N; Tihan T; Bollen AW; Northcott PA; Kool M; Pfister S; Korshunov A; Perry A; Solomon DA
Acta Neuropathol; 2018 Apr; 135(4):635-638. PubMed ID: 29435664
[No Abstract] [Full Text] [Related]
10. Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem.
Grammel D; Warmuth-Metz M; von Bueren AO; Kool M; Pietsch T; Kretzschmar HA; Rowitch DH; Rutkowski S; Pfister SM; Schüller U
Acta Neuropathol; 2012 Apr; 123(4):601-14. PubMed ID: 22349907
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling inhibits the Shh pathway and impairs tumor growth in Shh-dependent medulloblastoma.
Pöschl J; Bartels M; Ohli J; Bianchi E; Kuteykin-Teplyakov K; Grammel D; Ahlfeld J; Schüller U
Acta Neuropathol; 2014 Apr; 127(4):605-7. PubMed ID: 24531885
[No Abstract] [Full Text] [Related]
12. Subgroup-specific alternative splicing in medulloblastoma.
Dubuc AM; Morrissy AS; Kloosterhof NK; Northcott PA; Yu EP; Shih D; Peacock J; Grajkowska W; van Meter T; Eberhart CG; Pfister S; Marra MA; Weiss WA; Scherer SW; Rutka JT; French PJ; Taylor MD
Acta Neuropathol; 2012 Apr; 123(4):485-499. PubMed ID: 22358458
[TBL] [Abstract][Full Text] [Related]
13. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.
Kool M; Korshunov A; Remke M; Jones DT; Schlanstein M; Northcott PA; Cho YJ; Koster J; Schouten-van Meeteren A; van Vuurden D; Clifford SC; Pietsch T; von Bueren AO; Rutkowski S; McCabe M; Collins VP; Bäcklund ML; Haberler C; Bourdeaut F; Delattre O; Doz F; Ellison DW; Gilbertson RJ; Pomeroy SL; Taylor MD; Lichter P; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):473-84. PubMed ID: 22358457
[TBL] [Abstract][Full Text] [Related]
14. Notch1-induced brain tumor models the sonic hedgehog subgroup of human medulloblastoma.
Natarajan S; Li Y; Miller EE; Shih DJ; Taylor MD; Stearns TM; Bronson RT; Ackerman SL; Yoon JK; Yun K
Cancer Res; 2013 Sep; 73(17):5381-90. PubMed ID: 23852537
[TBL] [Abstract][Full Text] [Related]
15. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.
Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO
BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648
[TBL] [Abstract][Full Text] [Related]
16. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease.
Ellison DW
Acta Neuropathol; 2010 Sep; 120(3):305-16. PubMed ID: 20652577
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the genomic complexity underlying medulloblastoma.
Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.
Cambruzzi E
Childs Nerv Syst; 2018 May; 34(5):809-815. PubMed ID: 29582169
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Archer TC; Mahoney EL; Pomeroy SL
Neurotherapeutics; 2017 Apr; 14(2):265-273. PubMed ID: 28386677
[TBL] [Abstract][Full Text] [Related]
20. Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.
Clifford SC; Lusher ME; Lindsey JC; Langdon JA; Gilbertson RJ; Straughton D; Ellison DW
Cell Cycle; 2006 Nov; 5(22):2666-70. PubMed ID: 17172831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
